No abstract available
MeSH terms
-
Age Factors
-
Aged
-
Angiotensin I / antagonists & inhibitors*
-
Angiotensin Receptor Antagonists*
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
-
Anti-Arrhythmia Agents / administration & dosage
-
Anti-Arrhythmia Agents / therapeutic use
-
Antihypertensive Agents / administration & dosage
-
Antihypertensive Agents / therapeutic use
-
Benzimidazoles / administration & dosage
-
Benzimidazoles / therapeutic use
-
Biphenyl Compounds / administration & dosage
-
Biphenyl Compounds / therapeutic use
-
Captopril / administration & dosage
-
Captopril / therapeutic use
-
Clinical Trials as Topic
-
Death, Sudden, Cardiac / prevention & control
-
Enalapril / administration & dosage
-
Enalapril / therapeutic use
-
Heart Failure / drug therapy*
-
Heart Failure / mortality
-
Humans
-
Losartan / administration & dosage
-
Losartan / therapeutic use
-
Prodrugs
-
Prognosis
-
Randomized Controlled Trials as Topic
-
Risk Factors
-
Tetrazoles / administration & dosage
-
Tetrazoles / therapeutic use
-
Time Factors
Substances
-
Angiotensin Receptor Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Anti-Arrhythmia Agents
-
Antihypertensive Agents
-
Benzimidazoles
-
Biphenyl Compounds
-
Prodrugs
-
Tetrazoles
-
Enalapril
-
Angiotensin I
-
Captopril
-
Losartan
-
candesartan cilexetil
-
candesartan